These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 3292811)

  • 21. [Value of nifedipine in respiratory failure related to obstructive chronic bronchitis during treatment over 6 months].
    Meurice JC; Boutaud P; Herpin D; Ingrand P; Boita F; Underner M; Patte F
    Ann Cardiol Angeiol (Paris); 1989 Mar; 38(3):171-7. PubMed ID: 2735732
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hemodynamic effects of nifedipine in pulmonary hypertension.
    Klugmann S; Salvi A; Fioretti P; Camerini F
    G Ital Cardiol; 1982; 12(7):505-8. PubMed ID: 7169146
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Felodipine in primary pulmonary hypertension. Report of two cases.
    Arnman K; Rydén L; Smedgård P; Thorhallsson E
    Acta Med Scand; 1984; 215(3):275-80. PubMed ID: 6731040
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Drug therapy of pulmonary and portal hypertension in liver cirrhosis].
    Vorob'ev LP; Maev IV; Andreev NG
    Klin Med (Mosk); 1991 Feb; 69(2):64-7. PubMed ID: 1875666
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of vasodilator therapy on the clinical outcome of patients with primary pulmonary hypertension.
    Rich S; Brundage BH; Levy PS
    Circulation; 1985 Jun; 71(6):1191-6. PubMed ID: 3995712
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nifedipine and prazosin in the management of pulmonary hypertension in CREST syndrome.
    Glikson M; Pollack A; Dresner-Feigin R; Galun E; Rubinow A
    Chest; 1990 Sep; 98(3):759-61. PubMed ID: 2394157
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term treatment of chronic obstructive lung disease by Nifedipine: an 18-month haemodynamic study.
    Saadjian AY; Philip-Joet FF; Vestri R; Arnaud AG
    Eur Respir J; 1988 Aug; 1(8):716-20. PubMed ID: 3069486
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Variable hemodynamic response to nifedipine in pulmonary hypertension secondary to chronic obstructive bronchopathy and pulmonary fibrosis].
    Domenighetti G
    Schweiz Med Wochenschr; 1985 Sep; 115(39):1345-7. PubMed ID: 4071009
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The effect of nitrosorbide, korinfar and obzidan on the hemodynamics of patients with chronic hepatitis and liver cirrhosis based on the data acute drug trials].
    Vorob'ev LP; Maev IV
    Farmakol Toksikol; 1991; 54(5):54-7. PubMed ID: 1800153
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Primary pulmonary hypertension improved by long-term oral administration of nifedipine.
    Saito D; Haraoka S; Yoshida H; Kusachi S; Yasuhara K; Nishihara M; Fukuhara J; Hagashima H
    Am Heart J; 1983 Jun; 105(6):1041-2. PubMed ID: 6858827
    [No Abstract]   [Full Text] [Related]  

  • 31. Meta-analysis of the long-term effect of nifedipine for pulmonary hypertension.
    Malik AS; Warshafsky S; Lehrman S
    Arch Intern Med; 1997 Mar; 157(6):621-5. PubMed ID: 9080916
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Hemodynamic studies of nifedipine (Adalat) in pulmonary hypertension in childhood].
    Wimmer M; Schlemmer M; Ebner F
    Wien Klin Wochenschr; 1986 Nov; 98(21):740-3. PubMed ID: 3101292
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Pulmonary hemodynamics in patients with hypertension during acute drug tests using obsidan and corinfar].
    Maev IV; Vorob'ev LP; Kaziulin AN
    Kardiologiia; 1991 Mar; 31(3):61-3. PubMed ID: 1875602
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Hemodynamic effects of the administration of nifedipine over an 18-month period in pulmonary arterial hypertension in chronic obstructive bronchopneumopathies].
    Vestri R; Joet FP; Saadjian A; Arnaud A
    Presse Med; 1988 Feb; 17(5):213-4. PubMed ID: 2965386
    [No Abstract]   [Full Text] [Related]  

  • 35. Hemodynamic effects of nifedipine and oxygen in children with pulmonary hypertension.
    Wimmer M; Schlemmer M; Ebner F
    Cardiovasc Drugs Ther; 1988 Dec; 2(5):661-8. PubMed ID: 3154641
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nifedipine reduces pulmonary pressure and vascular tone during short- but not long-term treatment of pulmonary hypertension in patients with chronic obstructive pulmonary disease.
    Agostoni P; Doria E; Galli C; Tamborini G; Guazzi MD
    Am Rev Respir Dis; 1989 Jan; 139(1):120-5. PubMed ID: 2912331
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [10 years' experience in the use of vasodilator agents in the treatment of primary pulmonary arterial hypertension (P-PAH) (1977-1987)].
    Beltrán Gámez ME; Sandoval Zarate J; Seoane M; Lupi-Herrera E
    Arch Inst Cardiol Mex; 1988; 58(4):281-91. PubMed ID: 3190363
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transient effect of nifedipine on pulmonary hypertension of systemic sclerosis.
    Fudman EJ; Kelling DG
    J Rheumatol; 1985 Dec; 12(6):1191-2. PubMed ID: 4093929
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Decrease in pulmonary artery pressure with slow release nifedipine in Saudi patients with primary pulmonary hypertension.
    Ribeiro PA; Sivanandan V; Shaikh A; Chalak W; Zaman L; Duran CM
    Rev Port Cardiol; 1991 May; 10(5):413-8. PubMed ID: 1910877
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Pulmonary arterial hypertension treated with prostacyclin or calcium blockers].
    Andreassen AK; Geiran O; Madsen S; Hognestad A; Simonsen S
    Tidsskr Nor Laegeforen; 2003 Dec; 123(23):3393-6. PubMed ID: 14713978
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.